Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation

Background: Major concerns about the safety of pretransplant amiodarone use have been raised. As a result of its long half-life, the cardiac allograft is exposed to amiodarone posing potential risks such as bradycardia, requirement for pacemaker implantation, or increased mortality after heart trans...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rivinius, Rasmus (VerfasserIn) , Helmschrott, Matthias (VerfasserIn) , Ruhparwar, Arjang (VerfasserIn) , Darche, Fabrice Fernand (VerfasserIn) , Thomas, Dierk (VerfasserIn) , Bruckner, Thomas (VerfasserIn) , Katus, Hugo (VerfasserIn) , Dösch, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 June 2017
In: Drug design, development and therapy
Year: 2017, Jahrgang: 11, Pages: 1827-1837
ISSN:1177-8881
DOI:10.2147/DDDT.S136948
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.2147/DDDT.S136948
Verlag, kostenfrei, Volltext: https://www.dovepress.com/comparison-of-posttransplant-outcomes-in-patients-with-no-acute-or-chr-peer-reviewed-article-DDDT
Volltext
Verfasserangaben:Rasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, Fabrice F. Darche, Dierk Thomas, Thomas Bruckner, Hugo A. Katus, Andreas O. Doesch

MARC

LEADER 00000caa a2200000 c 4500
001 1562638122
003 DE-627
005 20230427122037.0
007 cr uuu---uuuuu
008 170822s2017 xx |||||o 00| ||eng c
024 7 |a 10.2147/DDDT.S136948  |2 doi 
035 |a (DE-627)1562638122 
035 |a (DE-576)492638128 
035 |a (DE-599)BSZ492638128 
035 |a (OCoLC)1263880570 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rivinius, Rasmus  |d 1986-  |e VerfasserIn  |0 (DE-588)1071009834  |0 (DE-627)825504309  |0 (DE-576)432876103  |4 aut 
245 1 0 |a Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation  |c Rasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, Fabrice F. Darche, Dierk Thomas, Thomas Bruckner, Hugo A. Katus, Andreas O. Doesch 
264 1 |c 19 June 2017 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.08.2017 
520 |a Background: Major concerns about the safety of pretransplant amiodarone use have been raised. As a result of its long half-life, the cardiac allograft is exposed to amiodarone posing potential risks such as bradycardia, requirement for pacemaker implantation, or increased mortality after heart transplantation (HTX).Objective: The aim of this study is to investigate the posttransplant outcomes of patients with no, acute, or chronic amiodarone use before HTX.Methods: This retrospective single-center study included 530 adult patients who received HTX between 06/1989 and 12/2012. Patients were stratified by their amiodarone therapy before HTX: no continuous amiodarone use (≤90 days before HTX), acute amiodarone use (≤90 days before HTX), and chronic amiodarone use (>90 days before HTX). Differences between the 3 groups in demographics, posttransplant medication, echocardiographic features, heart rates including occurrences of bradycardia, permanent pacemaker implantation, atrial fibrillation (AF), and survival were analyzed.Results: A total of 412 patients (77.7%) were in the “no amiodarone” group, 23 patients (4.4%) in the “acute amiodarone” group, and 95 patients (17.9%) in the “chronic amiodarone” group. Left ventricular ejection fraction (P=0.5819), heart rates including occurrence of bradycardia during posttransplant week 1 (P=0.0979 and P=0.2695), week 2 (P=0.1214 and P=0.8644), week 3 (P=0.1033 and P=0.8894), and week 4 (P=0.2892 and P=0.8644), permanent pacemaker implantation within 30-day (P=0.8644), or overall follow-up after HTX (P=0.8664) were not significant between groups. Patients with chronic pretransplant amiodarone therapy had the lowest rate of early posttransplant AF (P=0.0065). There was no statistically significant difference between groups in 30-day (P=0.8656), 1-year (P=1.0000), 2-year (P=0.8763), 5-year (P=0.5174), or overall posttransplant follow-up mortality (P=0.1936).Conclusion: Administration of acute or chronic pretransplant amiodarone was not related to an increased occurrence of bradycardia, requirement for permanent pacemaker implantation, or mortality after HTX. Importantly, chronic amiodarone use effectively reduced early AF after HTX, whereas acute amiodarone use showed no such effect. Keywords: amiodarone, atrial fibrillation, bradycardia, heart transplantation, pacemaker, survival 
700 1 |a Helmschrott, Matthias  |d 1986-  |e VerfasserIn  |0 (DE-588)1063822068  |0 (DE-627)812634187  |0 (DE-576)423257323  |4 aut 
700 1 |a Ruhparwar, Arjang  |e VerfasserIn  |0 (DE-588)138079021  |0 (DE-627)599042591  |0 (DE-576)306325926  |4 aut 
700 1 |a Darche, Fabrice Fernand  |d 1986-  |e VerfasserIn  |0 (DE-588)1074849833  |0 (DE-627)832587044  |0 (DE-576)442994982  |4 aut 
700 1 |a Thomas, Dierk  |d 1974-  |e VerfasserIn  |0 (DE-588)123896258  |0 (DE-627)706465601  |0 (DE-576)29393164X  |4 aut 
700 1 |a Bruckner, Thomas  |d 1956-  |e VerfasserIn  |0 (DE-588)136046215  |0 (DE-627)574429298  |0 (DE-576)300798768  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
700 1 |a Dösch, Andreas  |d 1976-  |e VerfasserIn  |0 (DE-588)129172758  |0 (DE-627)390355798  |0 (DE-576)297522310  |4 aut 
773 0 8 |i Enthalten in  |t Drug design, development and therapy  |d Albany, Auckland : Dove Medical Press, 2007  |g 11(2017), Seite 1827-1837  |h Online-Ressource  |w (DE-627)578533138  |w (DE-600)2451346-5  |w (DE-576)286025620  |x 1177-8881  |7 nnas  |a Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation 
773 1 8 |g volume:11  |g year:2017  |g pages:1827-1837  |g extent:11  |a Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation 
856 4 0 |u http://dx.doi.org/10.2147/DDDT.S136948  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.dovepress.com/comparison-of-posttransplant-outcomes-in-patients-with-no-acute-or-chr-peer-reviewed-article-DDDT  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20170822 
993 |a Article 
994 |a 2017 
998 |g 129172758  |a Dösch, Andreas  |m 129172758:Dösch, Andreas  |d 910000  |d 910100  |e 910000PD129172758  |e 910100PD129172758  |k 0/910000/  |k 1/910000/910100/  |p 8  |y j 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |e 910000PK108916618  |e 910100PK108916618  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 136046215  |a Bruckner, Thomas  |m 136046215:Bruckner, Thomas  |d 910000  |d 999701  |e 910000PB136046215  |e 999701PB136046215  |k 0/910000/  |k 1/910000/999701/  |p 6 
998 |g 123896258  |a Thomas, Dierk  |m 123896258:Thomas, Dierk  |d 910000  |d 910100  |e 910000PT123896258  |e 910100PT123896258  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1074849833  |a Darche, Fabrice Fernand  |m 1074849833:Darche, Fabrice Fernand  |d 910000  |d 910100  |e 910000PD1074849833  |e 910100PD1074849833  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 138079021  |a Ruhparwar, Arjang  |m 138079021:Ruhparwar, Arjang  |d 910000  |d 910200  |e 910000PR138079021  |e 910200PR138079021  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 1063822068  |a Helmschrott, Matthias  |m 1063822068:Helmschrott, Matthias  |d 910000  |d 910100  |e 910000PH1063822068  |e 910100PH1063822068  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1071009834  |a Rivinius, Rasmus  |m 1071009834:Rivinius, Rasmus  |d 910000  |d 910100  |e 910000PR1071009834  |e 910100PR1071009834  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1562638122  |e 297831415X 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Rasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, Fabrice F. Darche, Dierk Thomas, Thomas Bruckner, Hugo A. Katus, Andreas O. Doesch"]},"language":["eng"],"note":["Gesehen am 22.08.2017"],"recId":"1562638122","person":[{"role":"aut","family":"Rivinius","display":"Rivinius, Rasmus","given":"Rasmus"},{"display":"Helmschrott, Matthias","given":"Matthias","family":"Helmschrott","role":"aut"},{"family":"Ruhparwar","role":"aut","display":"Ruhparwar, Arjang","given":"Arjang"},{"family":"Darche","role":"aut","display":"Darche, Fabrice Fernand","given":"Fabrice Fernand"},{"given":"Dierk","display":"Thomas, Dierk","family":"Thomas","role":"aut"},{"given":"Thomas","display":"Bruckner, Thomas","family":"Bruckner","role":"aut"},{"display":"Katus, Hugo","given":"Hugo","role":"aut","family":"Katus"},{"display":"Dösch, Andreas","given":"Andreas","role":"aut","family":"Dösch"}],"id":{"eki":["1562638122"],"doi":["10.2147/DDDT.S136948"]},"physDesc":[{"extent":"11 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation","title_sort":"Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation"}],"origin":[{"dateIssuedDisp":"19 June 2017","dateIssuedKey":"2017"}],"relHost":[{"recId":"578533138","title":[{"title":"Drug design, development and therapy","title_sort":"Drug design, development and therapy"}],"id":{"zdb":["2451346-5"],"eki":["578533138"],"issn":["1177-8881"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2007-","publisher":"Dove Medical Press","publisherPlace":"Albany, Auckland","dateIssuedKey":"2007"}],"language":["eng"],"part":{"volume":"11","year":"2017","pages":"1827-1837","extent":"11","text":"11(2017), Seite 1827-1837"},"note":["Gesehen am 28.05.2020"],"pubHistory":["1.2007 -"],"disp":"Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantationDrug design, development and therapy","type":{"bibl":"periodical","media":"Online-Ressource"}}]} 
SRT |a RIVINIUSRACOMPARISON1920